Correction to: Blood Cancer Journal (2015) 5, e368; doi:10.1038/bcj.2015.88; published online 13 November 2015
Following the publication of this article, the authors noted the following errors:
1. The final sentence in the legend of Figure 1 should be 'Data are presented as the mean±s.e.m. of one-two experiments each in triplicate'.
2. The final sentence in the legend of Figure 3 should be 'Data are presented as the mean±s.e.m. of two-three independent experiments'.
3. We inadvertently duplicated a flow cytometry histogram in Figure 5C (right hand column 5th row and right hand column 6th row). This has been corrected in the revised version of Figure 5 as presented below:
Additional information
The online version of the original article can be found at 10.1038/bcj.2015.88
Rights and permissions
About this article
Cite this article
Phillips, D., Xiao, Y., Lam, L. et al. Erratum: Loss in MCL-1 function sensitizes non-Hodgkin’s lymphoma cell lines to the BCL-2-selective inhibitor venetoclax (ABT-199). Blood Cancer Journal 6, e403 (2016). https://doi.org/10.1038/bcj.2016.12
Published:
Issue Date:
DOI: https://doi.org/10.1038/bcj.2016.12